Ling Tong
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 5%
- Biomedical Engineering top 10%
- Cancer Research top 5%
- Co-authors
- Dean W. FelsherArvin M. GouwVirginie BaylotSusanne WalzKelly N. FitzgeraldMartin EilersInes GütgemannStephanie C. Casey
- Topics
- Cancer, Lipids, and Metabolism (3 papers)Nanoparticle-Based Drug Delivery (2 papers)CAR-T cell therapy research (2 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Ling Tong
11 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 871
- Oncology 730
- Immunology 595
- Biomedical Engineering 367
- Cancer Research 362
Countries citing papers authored by Ling Tong
This map shows the geographic impact of Ling Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Tong more than expected).
Fields of papers citing papers by Ling Tong
This network shows the impact of papers produced by Ling Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Tong. The network helps show where Ling Tong may publish in the future.
Co-authorship network of co-authors of Ling Tong
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Tong. A scholar is included among the top collaborators of Ling Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Tong. Ling Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 46 | |
| 6 | 146 | |
| 7 | 123 | |
| 8 | MYC regulates the antitumor immune response through CD47 and PD-L1breakdown → | 1018 |
| 9 | Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivobreakdown → | 425 |
| 10 | 12 | |
| 11 | 132 |
About Ling Tong
Ling Tong is a scholar working on Cancer Research, Physiology and Biomaterials, having authored 11 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (595 citations), Oncology (730 citations) and Cancer Research (362 citations). Ling Tong has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Dean W. Felsher, Arvin M. Gouw, Virginie Baylot, Susanne Walz, Kelly N. Fitzgerald, Martin Eilers, Ines Gütgemann, Stephanie C. Casey, Yulin Li and Jianghong Rao. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.